J HEPATOL 润色咨询

JOURNAL OF HEPATOLOGY

出版年份：暂无数据 年文章数：2346 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2016-08-07 ifmorethanten

    因为你在作者信息那里把别人的账号指定成通讯作者了。mengli1984 2016-06-21 发表::
    跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？

    mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2016-06-27 1dd96cb3m86(暂无匿称)

    3天就decison in process.感觉悲剧的节奏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2016-06-21 mengli1984

    跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-11-03 yangtian6666

    审稿速度:12.0 | 投稿命中率:25.0
    经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-08-26 ms9688259418763462

    审稿速度:1.0
    经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-07-29 218.82.113.4

    已经经历了第二次大修，求祝福！

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-06-21 ifmorethanten

    IF已经超过hepatology了···

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-04-21 lvvyy

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-03-16 bbpanda

    审稿速度:1.0
    经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。
    2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。
    3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=525618, encodeId=677a525618f2, content=因为你在作者信息那里把别人的账号指定成通讯作者了。<span class="quote">mengli1984 2016-06-21 发表::<br>跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？</span>, beContent=mengli1984 2016-06-21 发表:: 跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Aug 07 10:14:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524188, encodeId=9ef752418898, content=3天就decison in process.感觉悲剧的节奏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Mon Jun 27 06:41:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523997, encodeId=fb5352399e39, content=跪求各位大神，为什么我投稿时第一次信息没提交完毕，再次进入时前面提交的内容就都没了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Jun 21 19:17:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516536, encodeId=d6b3516536e9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：从去年圣诞节前夜投稿的，前后经历了四次大修，终于在今年10月中旬被最终接收。作为一篇回顾性临床研究，的确非常不容易。因为这些大牛杂志都是垄断在西方那些学术权威的喉舌下。想要发出东方的声音，真心不易。四次下来的修改答复，是原文的6倍之长，有将近100个问题。回想起来都一阵心酸，差点都想放弃改投别的杂志了。坚持，坚持，再坚持！拼了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d71613762, createdName=yangtian6666, createdTime=Tue Nov 03 17:56:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830890, encodeId=b23683089086, content=审稿速度:1.0<br>经验分享：已成为肝脏病杂志老大，近几年文章水平明显超过hepatology，投稿难度也越来越大，看好将来的发展趋势。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Wed Aug 26 09:44:41 CST 2015, time=2015-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513985, encodeId=870951398528, content=已经经历了第二次大修，求祝福！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=218.82.113.4, createdTime=Wed Jul 29 00:08:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512808, encodeId=d306512808da, content=IF已经超过hepatology了···, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sun Jun 21 11:29:00 CST 2015, time=2015-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511341, encodeId=f3d7511341b6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：投过1篇肝脏方面的临床研究的文章，没有送审三天后被拒，理由是文章虽然很有意思，但是投稿量太多，建议改投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e091615733, createdName=lvvyy, createdTime=Tue Apr 21 23:35:00 CST 2015, time=2015-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510528, encodeId=9036510528fe, content=审稿速度:1.0<br>经验分享：从这边得到了不少有用的信息，也和大家分享一下我的投稿经验。 <br> 2014年11月投的稿，投稿后一天with editor，三天后under review，一月后审稿结束，拒稿，但给机会重投。 <br> 3个审稿人给了几十条修改意见。花了1个半月时间按照审稿人意见逐条修改，并补充了几个小实验，投后审稿20天，接受并小修，再修改后3天接收。感觉遇到的reviewer挺好的，编辑稿件处理相当快，前后共4个月，主要是自己补实验、改稿件花了较长时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55591618104, createdName=bbpanda, createdTime=Mon Mar 16 22:51:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509543, encodeId=9a8a5095438c, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 18:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-03 sumer

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：编辑很快就拒了，理由是，我们研究的内容只描述了现象和危险因素，太初步了，希望能研究如何预防并发症等等。不过反正很快拒了，也不太浪费时间。

    0

共64条页码: 4/7页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分